Abstract
Epothilones are a promising class of drugs in clinical trials of prostate cancer that target the microtubules, similar to taxanes, and induce apoptosis in taxane resistant tumors. The tumor suppressor p53 is one important molecular mechanism of chemotherapy resistance that in some studies predicted tumor sensitivity to paclitaxel. We hypothesized that epothilone induced cytotoxicity would be influenced by the status of p53 in prostate cells. LNCaP, DU145, and a transformed rat prostate (RP) epithelial cell line with a temperature sensitive mutant p53 (val 135) were studied for the effect of epothilone on cell viability, cell cycle, and cell cycle checkpoint proteins. Epothilone had greater cytotoxicity in p53 mutant cancer cells compared to wild type cells. We confirmed our findings by creating a transformed RP epithelial cell line with a temperature sensitive mutant p53 (val 135). Using a tetrazolium (MTT) assay we found that epothilone (100 nM) decreased cell viability in RP cells by 90% with mutant p53 compared to 45% with wild type p53 (P < 0.01). Epothilone induced G2/M arrest in 50% of cells with mutant p53 compared to 25% with wild type p53 (P < 0.01). To begin to understand mechanism of epothilone induced G2/M arrest, w...Continue Reading
References
Jan 1, 1993·The Prostate·A G CarrollE P Gelmann
Jul 21, 1998·The Journal of Biological Chemistry·Y H LingR Perez-Soler
Nov 15, 2000·Oncogene·A ThomasE White
Sep 6, 2001·The Prostate·C LanziF Zunino
Feb 7, 2002·Journal of Agricultural and Food Chemistry·Mohamed M RafiRobert S DiPaola
May 28, 2003·Cancer Chemotherapy and Pharmacology·A ThalasilaRobert S DiPaola
Jun 13, 2003·Seminars in Oncology·John RothermelJohn Hohneker
Sep 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O SmaletzW K Kelly
Citations
May 12, 2005·Urology·Robert S Dipaola, Ian M Thompson
Dec 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HussainA R Johri
Apr 8, 2006·American Journal of Clinical Oncology·Guru Sonpavde, Thomas E Hutson
Apr 4, 2007·Genes & Development·Tsutomu ShimazuMasayori Inouye
May 12, 2011·PloS One·Sebastian WinselJens Hoffmann
Feb 14, 2012·Biochemical Pharmacology·Yakun ChenDaotai Nie
Dec 18, 2007·Neoplasia : an International Journal for Oncology Research·Fatouma AlimirahDivaker Choubey
Jul 24, 2007·The Journal of Urology·Paul Mathew, Robert Dipaola
Sep 4, 2008·The Prostate·Robert S DiPaolaEileen White
Sep 15, 2005·The Prostate·Laurie FeldmanArthur J Sytkowski
Aug 21, 2013·Cell Biology International·Aneta RogalskaAgnieszka Marczak
Feb 7, 2006·Cancer Treatment Reviews·Guru SonpavdeWilliam R Berry
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew D GalskyW Kevin Kelly
Apr 26, 2006·Oncogene·C SunS Srivastava
Sep 17, 2005·Cancer Research·Balakrishnan RamanathanYeong-Shiau Pu